ICU trial aims to curb opiate dependence with safer painkiller
NCT ID NCT06819956
Summary
This study is testing if a common anti-inflammatory drug (ketorolac) can be used at lower doses to safely reduce pain in ICU patients, with the goal of decreasing their need for strong opiate painkillers. It's a small pilot study with 30 participants to see if a larger trial is possible. Researchers want to know if this approach can help control pain while lowering the risk of future opiate dependence.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alberta Hospital
RECRUITINGEdmonton, Alberta, T6G 2B7, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.